Game Changers (544594)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 71.16% indicates exceptional capital efficiency
• P/E of 12.92 and PEG of 0.40 suggest attractive valuation relative to reported profit growth
• Piotroski F-Score of 7/9 points to solid financial health
• Latest quarter net profit of ₹8 Cr on sales of ₹57 Cr shows strong margin performance

Concerns

• Sales growth of only 3.87% while profit growth is 60.42% raises sustainability questions
• No dividend yield, so returns depend entirely on price appreciation
• Missing data on book value, debt/equity, and promoter holding limits thorough analysis
• Textile industry is cyclical and competitive, making high margins vulnerable

AI Analysis

Game Changers presents an intriguing but incomplete picture. At ₹109.75, the market cap is ₹196 Cr and the P/E is 12.92, which is not demanding. The ROCE of 71.16% is striking — any business earning that kind of return on capital deserves attention. The Piotroski F-Score of 7 out of 9 also suggests the company's financial health is reasonably sound. However, I am bothered by the disconnect between sales growth and profit growth. Sales grew only 3.87%, while profits jumped 60.42%. That kind of divergence can be a sign of margin expansion, cost discipline, or cyclical tailwinds, but it is not the same as durable compounding. In textiles, a fiercely competitive and capital-heavy industry, high margins can fade quickly. The latest quarter shows sales of ₹57 Cr and net profit of ₹8 Cr, which is a strong margin, but I need to know if this is sustainable. The PEG ratio of 0.40 makes the stock look cheap if the profit growth continues, but that is a big 'if'. The absence of dividend yield means shareholders expect all returns from capital appreciation. More concerning is the lack of data: no book value, no debt-equity ratio, no promoter holding, and no 52-week range. I cannot calculate a proper margin of safety without these figures. I would not ignore a business with such high ROE-like returns, but I would not buy blindly either. This looks like a fast grower with genuine momentum, but the slow sales growth and missing disclosures keep me cautious. I want evidence that the profit surge is not a one-off before committing capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer